FDA Issues Complete Response Letter for Intuniv (guanfacine) Extended Release

Shire plc, the global specialty biopharmaceutical company, announces that it has received a Complete Response letter today for INTUNIV(TM) (guanfacine) Extended Release from the FDA.

The details can be read here.